Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001645666-25-000027
Filing Date
2025-05-13
Accepted
2025-05-13 16:11:25
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-20250331.htm   iXBRL 10-Q 1166303
2 EX-31.1 kzr-20250331xexx311.htm EX-31.1 10451
3 EX-31.2 kzr-20250331xexx312.htm EX-31.2 10379
4 EX-32.1 kzr-20250331xexx321.htm EX-32.1 5966
  Complete submission text file 0001645666-25-000027.txt   6409876

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kzr-20250331.xsd EX-101.SCH 49448
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kzr-20250331_cal.xml EX-101.CAL 64540
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kzr-20250331_def.xml EX-101.DEF 197185
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kzr-20250331_lab.xml EX-101.LAB 603002
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kzr-20250331_pre.xml EX-101.PRE 409422
82 EXTRACTED XBRL INSTANCE DOCUMENT kzr-20250331_htm.xml XML 799423
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 25940202
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)